HCV Microfluidic Diagnostics - Trial NCT06047275
Access comprehensive clinical trial information for NCT06047275 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Hull and is currently Recruitment Completed. The study focuses on Hepatitis C. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
University of Hull
Timeline & Enrollment
N/A
May 01, 2023
May 31, 2024
Primary Outcome
Positivity
Summary
Hepatitis C diagnostic devices have been developed at the University of Hull to detect and
 quantify the Hepatitis C virus in patients' plasma and serum samples. This study aims to test
 the new point-of-care devices that are designed to be low cost and user-friendly.
 
 Excess, stored, HCV patients' plasma, serum and blood samples will be supplied by the
 Virology laboratory (Hull University Teaching Hospital's Trust; HUTH). These samples were
 taken and analysed as part of patients' clinical monitoring, and are stored prior to disposal
 in the Virology laboratory. The proposed study will use the samples in a fully anonymised
 manner.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06047275
Non-Device Trial